Unleash the Power of The Press

pharmaceutical

SelecTech Launches Dedicated Health Care Division and Custom Flooring

SelecTech, Inc., a leader in the manufacture of innovative flooring products from recycled materials and a vendor partner of Health Care Institute, has recently launched a dedicated Health Care Division.

SelecTech is the creator of the top performing, 70 percent recycled content, 100 percent recyclable FreeStyle commercial flooring line, as well as the FreeStyle ESD flooring line, which is renowned as an interlocking conductive flooring powerhouse that is essential to health care organizations utilizing electronic data. FreeStyle and FreeStyle ESD have been customized and are now available in new styles and colors specific to heath care organizations.

Evidence-Based Design

Using the concept of evidence based design; SelecTech took a number of health care issues into consideration during the design phase – from medical waste and infection control issues to workplace safety issues and noise and injury reduction issues. Revenue stream is also a major consideration to many health care facilities, as they are unable to shut down for renovations. The unique interlock system on SelecTech’s flooring products enable floors to be installed quickly, at a much lower cost, without adhesives, and without a lot of costly downtime or disruption. For these reasons, SelecTech’s solutions provide significant value to many health care organizations including independent clinics, private medical practices, academic medical centers, hospitals, surgical centers and retirement facilities.

LEED Points

SelecTech’s innovative FreeStyle flooring is easy to install and does not require messy adhesives, copper foil, underlayments or padding. FreeStyle flooring can help contribute to LEED points and is 100 percent “cradle-to-cradle recovery”, meaning that SelecTech’s products are 100 percent recyclable back into new Freestyle flooring. Health care industry clients that utilize SelecTech’s flooring include Kaleida Women’s and Children’s Hospital, GlaxoSmithKline and BC Biomedical Laboratories.

To learn more about SelecTech’s FreeStyle and FreeStyle ESD flooring for health care, visit http://www.selectechinc.com.

About SelecTech, Inc.

SelecTech, Inc. was founded in 1993 with the mission of creating valuable products from scrap plastics. The company has become a leader in the manufacture of flooring products from recycled materials and uses one million pounds of recycled materials annually. Their products are made with up to 100 percent recycled content, are 100 percent recyclable and installed without adhesives making them some of the “greenest” and most cost-effective flooring products available. The unique interlock system on SelecTech’s flooring products enable them to be installed at a much lower cost, without a lot of costly downtime, which provides significant value to customers.

Using state-of-the-art technology and innovative product design, SelecTech created the top performing Place N’ Go residential flooring products, which are available at Home Depot. They are also the creators of the renowned commercial and industrial FreeStyle, FreeStyle ESD and StaticStop ESD flooring lines.

SelecTech is a vendor partner of Health Care Institute, an International Facility Management Association (IFMA) alliance partner. The company is headquartered at 33 Wales Avenue, Suite F in Avon, MA. For more information about SelecTech, visit http://www.selectechinc.com.

SelecTech Launches Dedicated Health Care Division and Custom FlooringRead More

RI and MA participants in HIN1 (Swine) Flu vaccine studies to receive vaccinations early.

DATELINE: WARWICK, RI…
The race is on to find the most effective H1N1 (Swine) flu vaccine in time for inoculations this fall. As part of this effort, Omega Medical Research in Warwick, Rhode Island has announced that it will be conducting several investigational HIN1 Flu vaccine studies starting in August to assist in the development of a safe and effective vaccine.

On June 11, 2009 the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6 in response to the ongoing spread of the novel influenza A (H1N1) virus commonly known as Swine Flu. WHO stated, “The 2009 influenza pandemic has spread internationally with unprecedented speed. In past pandemics, influenza viruses have needed more than six months to spread as widely as the new H1N1 virus has spread in less than six weeks.”

David L. Fried, MD, the medical director for Omega Medical Research, and the Principal Investigator on investigational HIN1 Flu vaccine studies to be conducted at the center, stressed the urgency of this undertaking, “At this time, the best preventative measure to avoid H1N1 is to receive vaccination and immunization.  Omega Medical Research is conducting one of the few studies in the country that provides the initial vaccine to volunteers who participate in this important study.”

Recent comments from Dr. Anne Schuchat, director of the National Center for Immunization and Respiratory Diseases at the CDC (Centers for Disease Control and Prevention) indicate that the virus is not going away and that the 2009 H1N1 virus patterns are quite different from seasonal influenza, “This virus is continuing to cause illness here in the U.S. even in the summer and continues to affect a generally younger population than what we see in terms of the seasonal influenza.”

Schuchat continued, “We do expect there to be an increase in influenza that occurs this fall, perhaps earlier than what we see with seasonal influenza. In particular, we think there may be challenges when people return to schools and our communities get back into the sort of the regular times with lots of kids congregated together.”

This spring several Rhode Island schools closed temporarily due to H1N1 (Swine) flu concerns including the Greystone Elementary School in North Providence, North Kingstown High School, and the Pier Middle School in Narragansett. In Southeastern Massachusetts the Assawompsett Elementary School in Lakeville and the Mary Fonseca Elementary School in Fall River both closed temporarily this spring due to H1N1 (Swine) flu outbreaks. To date, 2 H1N1 (Swine) flu deaths have been confirmed in Rhode Island and 6 deaths in Massachusetts.

Residents of Rhode Island and Southeastern Massachusetts who would like to participate in Omega Medical Research’s investigational HIN1 Flu vaccine studies should contact Patty Feole, RN at 401-739-3573 as soon as possible. Volunteers are needed in four age groups: 6 to 35 months; 2 years to 17 years; 18 years to 64 years; and 65 years and older. Study participants will receive compensation for their time and travel to Omega Medical Research, which is conveniently located near Routes 295 and 95 in Warwick, Rhode Island.

Clinical Research Center of Excellence
Omega Medical Research, founded in 1993, is a nationally recognized clinical research center providing accurate, efficient, and high quality clinical trials services to the pharmaceutical, nutraceutical, and medical device industries. Omega Medical Research is located at 400 Bald Hill Road in Warwick, RI, conveniently adjacent to Routes 295 and 95. Their hours of operation are: Monday 7:30am-4:30pm, Tuesday 7:30am-4:30pm, Wednesday 7:30am-5:30pm, Thursday 7:30am-4:30pm, and Friday 8:00am-2:00pm.

Omega Medical Research has extensive experience with vaccine protocols and is a member of the Alliance for Multispecialty Research (AMR), a unique network of independently owned, geographically diverse, and highly experienced Clinical Research Centers of Excellence. Membership in AMR is by invitation only and is the culmination of a rigorous review and acceptance process.

For additional information please contact Patty Feole, RN at 401-739-3573, or visit www.omegastudies.com.

RI and MA participants in HIN1 (Swine) Flu vaccine studies to receive vaccinations early.Read More